JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Eosinophilic gastrointestinal disorders.

Eosinophilic gastrointestinal disorders (EGID) are frequently encountered by the practicing allergist/immunologist. This is due to the occurrence of the disorders in atopic subjects and because research has indicated that atopy-related genes, inflammatory cells, and mediators play a role in the pathogenesis of the disorders. The role of the allergist/immunologist includes making the diagnosis by eliciting the symptoms in the history and defining the atopic phenotype of the subject with regard to food and environmental allergens, using skin testing and possibly patch tests. Obtaining a tissue diagnosis with an esophagogastroduodenoscopy is essential for the diagnosis and may direct treatment with topical steroids, diet, or novel therapeutic agents, e.g., anti-IL-5 monoclonal antibodies. The allergist/immunologist also contributes to the management and design of therapeutic interventions and the long-term follow-up of the patients. This is important because the EGID have a chronic course marked by resolutions and relapses. This review takes a practical approach to the identification and management of the EGID by the allergist/immunologist.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app